SCHEMBL8100641

SCHEMBL8100641

CC(=COc1ccc(C(=O)O)c(C)c1I)c1ccc2c(c1)C(C)(C)CCC2(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARG P13631 14/20 0.50
RXRA P19793 14/20 0.50
RARA P10276 12/20 0.50
RARB P10826 12/20 0.50
CYP26A1 O43174 3/20 0.50
CYP3A4 P08684 2/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
CYP2D6 P10635 1/20 0.50
NFKB1 P19838 1/20 0.50
CYP2C19 P33261 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7771294 0.83 RARG (0.57) RARGRXRARARARARBCYP26A1
SCHEMBL7771292 0.83 RARG (0.57) RARGRXRARARARARBCYP26A1
SCHEMBL7769560 0.81 RARG (0.57) RARGRXRARARARARBCYP26A1
SCHEMBL7769562 0.81 RARG (0.57) RARGRXRARARARARBCYP26A1
SCHEMBL6733979 0.77 CYP3A4 (0.49) RARGRXRARARARARBCYP26A1
SCHEMBL6733982 0.77 CYP3A4 (0.49) RARGRXRARARARARBCYP26A1
SCHEMBL6730316 0.74 CYP3A4 (0.49) RARGRXRARARARARBCYP26A1
SCHEMBL6730317 0.74 CYP3A4 (0.49) RARGRXRARARARARBCYP26A1
SCHEMBL7771734 0.72 RXRA (0.58) RARGRXRARARARARBCYP26A1
SCHEMBL7771737 0.72 RXRA (0.58) RARGRXRARARARARBCYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030952-A AS HUMAN AND VETERINARY MEDICINE, PARTICULARLY IN THE TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHTHALMOLOGIC CONDITIONS, AND IN COSMETIC COMPOSITIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES GALDERMA (FR) 2000-02-29 US disclosed